GB2442161B - Triglycerides - Google Patents

Triglycerides

Info

Publication number
GB2442161B
GB2442161B GB0724618A GB0724618A GB2442161B GB 2442161 B GB2442161 B GB 2442161B GB 0724618 A GB0724618 A GB 0724618A GB 0724618 A GB0724618 A GB 0724618A GB 2442161 B GB2442161 B GB 2442161B
Authority
GB
United Kingdom
Prior art keywords
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0724618A
Other versions
GB2442161A (en
GB0724618D0 (en
Inventor
Michael J Leach
Laurence S Harbige
Mohammed Sharief
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BTG International Ltd
Original Assignee
BTG International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0319358A external-priority patent/GB0319358D0/en
Priority claimed from GB0410846A external-priority patent/GB0410846D0/en
Application filed by BTG International Ltd filed Critical BTG International Ltd
Priority to GB0724618A priority Critical patent/GB2442161B/en
Priority claimed from GB0603646A external-priority patent/GB2422373B/en
Publication of GB0724618D0 publication Critical patent/GB0724618D0/en
Publication of GB2442161A publication Critical patent/GB2442161A/en
Application granted granted Critical
Publication of GB2442161B publication Critical patent/GB2442161B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0724618A 2003-08-18 2004-08-13 Triglycerides Expired - Fee Related GB2442161B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0724618A GB2442161B (en) 2003-08-18 2004-08-13 Triglycerides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0319358A GB0319358D0 (en) 2003-08-18 2003-08-18 Treatment of neurodegenerative conditions
GB0410846A GB0410846D0 (en) 2004-05-14 2004-05-14 Treatment of neurodegenerative conditions
GB0603646A GB2422373B (en) 2003-08-18 2004-08-13 Treatment of neurodegenerative conditions
GB0724618A GB2442161B (en) 2003-08-18 2004-08-13 Triglycerides

Publications (3)

Publication Number Publication Date
GB0724618D0 GB0724618D0 (en) 2008-01-30
GB2442161A GB2442161A (en) 2008-03-26
GB2442161B true GB2442161B (en) 2008-05-21

Family

ID=39126167

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0724618A Expired - Fee Related GB2442161B (en) 2003-08-18 2004-08-13 Triglycerides

Country Status (1)

Country Link
GB (1) GB2442161B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
WO2001097793A2 (en) * 2000-06-23 2001-12-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
WO2003013497A1 (en) * 2001-08-02 2003-02-20 Suntory Limited Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
GB2415378A (en) * 2003-05-14 2005-12-28 Btg Int Ltd Use of triglyceride oils containing gamma-linolenic acid residues and linolenic acid residues for the treatment of neurogenerative disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
WO2001097793A2 (en) * 2000-06-23 2001-12-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
WO2003013497A1 (en) * 2001-08-02 2003-02-20 Suntory Limited Compositions having effects of preventing or ameliorating conditions or diseases caused by brain hypofunction
GB2415378A (en) * 2003-05-14 2005-12-28 Btg Int Ltd Use of triglyceride oils containing gamma-linolenic acid residues and linolenic acid residues for the treatment of neurogenerative disease

Also Published As

Publication number Publication date
GB2442161A (en) 2008-03-26
GB0724618D0 (en) 2008-01-30

Similar Documents

Publication Publication Date Title
DE502004011703D1 (en) N-heterocyclyl-phenylsubstituierte cyclische ketoenole
EP1635758A4 (en) Orthodynamic rehabilitator
EP1615948A4 (en) Immuno-amplification
DE602004012071D1 (en) T-hilfe
DE602004020356D1 (en) Phenoxyessigsäurederivate
DE602004030538D1 (en) Präzisionssubstratlagerbehälter
EP1629178A4 (en) Rockbolt
DE602004027010D1 (en) Thermotherapiehülle
DE502004003476D1 (en) Standfuss
DE502004011852D1 (en) Nspritzventil
DE502004004146D1 (en) Pyrazolverbindungen
DE112004002769D2 (en) Schienengeführtes transportsystem
DE60333037D1 (en) Laser-radar
DK1665437T3 (en) Reformeringsmodul
DE602004012262D1 (en) Benzimidazolonverbindung
DE502004011343D1 (en) Rotorspinnmaschine
DE602004020525D1 (en) Imidazolderivate
DE502004012153D1 (en) Rotorspinnmaschine
DE10394343D2 (en) Berührungslose biometrische erkennung
HU2598U (en) Quick-joint
DE602004009041D1 (en) Hydroxytetrahydronaphthalenylharnstoffderivate
GB0326454D0 (en) Magik top
DE602004008281D1 (en) Avermectin-b1-monosaccharidderivative
GB2442161B (en) Triglycerides
EP1698434A4 (en) Geinder

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20120927 AND 20121003

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20220813